Our Technology
Pyovita’s technology targets the dense extracellular matrix that surrounds and protects colorectal tumors.
This barrier can limit drug penetration, shield resistant cancer cells, suppress immune activity, and support tumor progression.
Our therapeutic is designed to become active under the acidic conditions found in the tumor microenvironment. It remodels the extracellular matrix, helping expose protected cancer cells and improve access for anticancer drugs and immune cells.
We are developing the technology in two formats: as a standalone therapeutic for use with existing cancer treatments and through beneficial bacteria designed to deliver and produce it locally within tumors.
